Risk of atherosclerosis-related diseases in polymyositis and dermatomyositis patients: A large-scale population-based

Lior Fisher1, Niv Ben-Shabat1, Omer Gendelman1

  • 1Department of Internal Medicine B & Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Israel. Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Atherosclerosis
|January 16, 2025
PubMed

Insights

Polymyositis (PM) and dermatomyositis (DM) increase the risk of heart attack and stroke. Patients with PM/DM and APLA-associated antibodies face even higher Atherosclerotic Cardiovascular Disease (ASCVD) rates.

Area of Science:

  • Rheumatology
  • Cardiology
  • Neurology

Background:

  • Systemic autoimmune diseases, including polymyositis (PM) and dermatomyositis (DM), are linked to increased Atherosclerotic Cardiovascular Disease (ASCVD).
  • Inflammation plays a crucial role in atherogenesis, but the specific association between PM/DM and ASCVD events remains underexplored.

Purpose of the Study:

  • To investigate the association between PM/DM and ASCVD events.
  • To examine the incidence, mortality, and interaction of disease-modifying agents, autoantibodies, and traditional cardiovascular disease (CVD) risk factors in a large population-based sample.

Main Methods:

  • A retrospective cohort study was conducted using electronic health records from Clalit Health Services (CHS).
  • 1899 PM/DM patients diagnosed between 2000-2016 were matched with 7676 healthy controls (1:5 ratio) by age and sex.
  • ASCVD incidence was compared between groups using univariate and multivariate models, adjusting for baseline CVD risk factors.

Main Results:

  • PM/DM patients had a significantly higher incidence of ischemic heart disease (IHD) (HR 1.61) and cerebrovascular accident (CVA) (HR 2.45) compared to controls.
  • The overall risk for ASCVD was elevated in the PM/DM group (HR 1.75).
  • Patients with PM/DM positive for APLA-associated antibodies showed a significantly higher ASCVD risk (OR 2.33).

Conclusions:

  • Polymyositis and dermatomyositis are associated with an increased risk of IHD and CVA.
  • PM/DM patients with APLA-associated antibodies exhibit particularly high rates of ASCVD.
  • Increased awareness and surveillance for cardiovascular, neurological, and vascular outcomes are warranted for PM/DM patients.
Abstract

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.2K
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
385
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
55
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
863
Skin Diseases and Disorders01:23

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
2.8K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K